Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
NEW JCM GROUP
300157
5
Shenzhen S-king Intelligent Equipment
688328
US OptionsDetailed Quotes
ABBV250502C160000
- 25.90
- 0.000.00%
15min DelayClose Apr 28 15:59 ET
0.00High0.00Low
25.90Open25.90Pre Close0 Volume2 Open Interest160.00Strike Price0.00Turnover112.69%IV-3.35%PremiumMay 2, 2025Expiry Date32.34Intrinsic Value100Multiplier4DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9515Delta0.0045Gamma5.85Leverage Ratio-0.2743Theta0.0157Rho5.57Eff Leverage0.0198Vega
AbbVie Newsroom
Why AbbVie Stock Trounced the Market Today
S&P 500 Gains and Losses Today: AbbVie Stock Advances After Beat-and-Raise Earnings Report
Equity Markets Mixed Before Key Earnings, Macro Data
AbbVie Immunology Portfolio Poised For Growth Through Humira Erosion: Analyst
AbbVie's Options Frenzy: What You Need to Know
Express News | AbbVie Shares Are Trading Higher After Multiple Analysts Raised Their Price Targets on the Stock. The Company Last Week Reported Better-than-expected Q1 Financial Results and Raised Its FY25 Adjusted EPS Guidance
Express News | Evercore ISI Group Maintains Outperform on AbbVie, Raises Price Target to $205
Fund Update: KEYBANK NATIONAL ASSOCIATION/OH Just Disclosed New Holdings
Morgan Stanley Maintains Overweight on AbbVie, Raises Price Target to $250
AbbVie Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Tvardi Therapeutics (TVRD) and AbbVie (ABBV)
Raymond James Adjusts Price Target on AbbVie to $227 From $220, Maintains Outperform Rating
Citi Sticks to Its Buy Rating for AbbVie (ABBV)
AbbVie Stock Rises Despite Risks as Earnings Beat Forecasts
Express News | Abbvie Inc : HSBC Cuts Target Price to $205 From $230
AbbVie Inc. (ABBV): Among Billionaire Ken Fisher's Healthcare Stock Picks With Massive Upside Potential
Notable Healthcare Headlines for the Week: Merck, Roche and Bausch Health in Focus
No Misses Here: Healthcare Earnings Sweep Past Wall Street Estimates
AbbVie Reports Strong Q1 2025 Financial Results
How Much Would It Take To Earn $100 A Month From AbbVie Stock
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 9 20:29
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
